Eur Neurol. 2004 Jun 22;52(1):12-17
Lucas M, Zayas MD, De Costa AF, Solano F, Chadli A, Dinca L, Izquierdo G.
Servicio de Biologia Molecular, Hospital Universitario Virgen Macarena, Sevilla, Spain.
We studied the association between multiple sclerosis (MS) and a novel single nucleotide polymorphism (SNP), A/T(735)G/C, localized in intron IV of the ApoI/Fas gene, which is recognized by the restrictase MaeI.
Fas-MaeI genotypes were screened in chromosomes of 215 healthy individuals and 312 relapsing MS patients of Spanish extraction.
We also analyzed the interaction of this new intragenic marker with others previously associated with MS: class II HLA-DRB1*1501, Fas-MvaI and Fas ligand.
The distribution of Fas-MaeI genotypes was in equilibrium in the control cohort, while a significant disequilibrium was observed in the patient group (chi(2) = 16; p = 0.0003).
Fas-MaeI genotypes were statistically different in the MS and control groups, but the allele frequencies were not.
Sharing of MvaI/MaeI genotypes of the promoter/intron IV region did not differ between patients and controls.
We failed to find different frequencies of ApoI/Fas genotypes in the population of MS carriers of the class II HLA-DRB1*1501 allele.
The case/control comparative study showed a relative risk (OR close to 1.6) of MS in individuals harboring the T and A alleles of Fas- MaeI and Fas ligand, respectively.
In conclusion, our findings suggest a weak association between the intronic marker Fas-MaeI and MS and a relative interaction with Fas ligand in an MS cohort of South Spanish extraction.